These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 64469)

  • 1. Structure of tetanus toxin. II. Toxin binding to ganglioside.
    Helting TB; Zwisler O; Wiegandt H
    J Biol Chem; 1977 Jan; 252(1):194-8. PubMed ID: 64469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin.
    Louch HA; Buczko ES; Woody MA; Venable RM; Vann WF
    Biochemistry; 2002 Nov; 41(46):13644-52. PubMed ID: 12427026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tetanus toxin fragment C binding to ganglioside G(T1b) by monoclonal antibodies recognizing different epitopes.
    Fitzsimmons SP; Clark KC; Wilkerson R; Shapiro MA
    Vaccine; 2000 Aug; 19(1):114-21. PubMed ID: 10924793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand.
    Shapiro RE; Specht CD; Collins BE; Woods AS; Cotter RJ; Schnaar RL
    J Biol Chem; 1997 Nov; 272(48):30380-6. PubMed ID: 9374528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding.
    Emsley P; Fotinou C; Black I; Fairweather NF; Charles IG; Watts C; Hewitt E; Isaacs NW
    J Biol Chem; 2000 Mar; 275(12):8889-94. PubMed ID: 10722735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.
    Helting TB; Zwisler O
    J Biol Chem; 1977 Jan; 252(1):187-93. PubMed ID: 401808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of tetanus toxin: the arrangement of papain digestion products within the heavy chain-light chain framework of extracellular toxin.
    Neubauer V; Helting TB
    Biochim Biophys Acta; 1981 Mar; 668(1):141-8. PubMed ID: 7016194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against tetanus toxin and toxoid.
    Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
    Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of functional fragment C of tetanus toxin.
    Halpern JL; Habig WH; Neale EA; Stibitz S
    Infect Immun; 1990 Apr; 58(4):1004-9. PubMed ID: 2318526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospray mass spectrometry of NeuAc oligomers associated with the C fragment of the tetanus toxin.
    Conway MCP; Whittal RM; Baldwin MA; Burlingame AL; Balhorn R
    J Am Soc Mass Spectrom; 2006 Jul; 17(7):967-976. PubMed ID: 16713287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.
    Yousefi M; Khosravi-Eghbal R; Reza Mahmoudi A; Jeddi-Tehrani M; Rabbani H; Shokri F
    Hum Vaccin Immunother; 2014; 10(2):344-51. PubMed ID: 24126015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutants of tetanus toxin Hc fragment: ganglioside binding, cell binding and retrograde axonal transport properties.
    Sinha K; Box M; Lalli G; Schiavo G; Schneider H; Groves M; Siligardi G; Fairweather N
    Mol Microbiol; 2000 Sep; 37(5):1041-51. PubMed ID: 10972823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
    Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
    Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetanus toxin association with developing neuronal cell cultures. Kinetic parameters and evidence for ganglioside-mediated internalization.
    Yavin E; Yavin Z; Habig WH; Hardegree MC; Kohn LD
    J Biol Chem; 1981 Jul; 256(13):7014-22. PubMed ID: 7240260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.
    Fotinou C; Emsley P; Black I; Ando H; Ishida H; Kiso M; Sinha KA; Fairweather NF; Isaacs NW
    J Biol Chem; 2001 Aug; 276(34):32274-81. PubMed ID: 11418600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chains and fragments of tetanus toxin. Separation, reassociation and pharmacological properties.
    Weller U; Dauzenroth ME; Meyer zu Heringdorf D; Habermann E
    Eur J Biochem; 1989 Jul; 182(3):649-56. PubMed ID: 2753037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity.
    Rummel A; Bade S; Alves J; Bigalke H; Binz T
    J Mol Biol; 2003 Feb; 326(3):835-47. PubMed ID: 12581644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the immune response to papain digestion products of tetanus toxin.
    Helting TB; Nau HH
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for tetanus toxin coreceptor interactions.
    Chen C; Baldwin MR; Barbieri JT
    Biochemistry; 2008 Jul; 47(27):7179-86. PubMed ID: 18543947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.